Indo-Irish biotech startup CyGenica secures funding from SOSV to accelerate cancer and rare genetic disease therapy
Share this article Share this article PUNE, India and CORK, Ireland, June 10, 2021 /PRNewswire/ -- CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV. The funding round will accelerate validation of CyGenicas proprietary technology, which enables safe, targeted and affordable intercellular drug delivery. The current investment seed round was led by venture capital investor SOSV. Other investors participating i...
Source: prnewswire.com